Use of the Levonorgestrel Intrauterine Device in an Adolescent with Type IV Vascular Ehlers-Danlos Syndrome and Heavy Menstrual Bleeding, a Case Report

Mary K. Wilde; Genevieve Moyer; Patricia Huguelet

doi:10.1016/j.jpag.2023.02.001

Use of the Levonorgestrel Intrauterine Device in an Adolescent with Type IV Vascular Ehlers-Danlos Syndrome and Heavy Menstrual Bleeding, a Case Report

Mary K. Wilde, Genevieve Moyer, Patricia Huguelet

In: Journal of Pediatric and Adolescent Gynecology · 2023 · vol. 36(3) , pp. 331–333 · doi:10.1016/j.jpag.2023.02.001 · PMID:36813023 · W4321460700

article OA: closed CC0

View on OpenAlex View on PubMed View at publisher

⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-11 ⓘ

This case report describes the successful use of a levonorgestrel intrauterine device in an adolescent with Type IV vascular Ehlers-Danlos syndrome experiencing heavy menstrual bleeding.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

BackgroundEhlers-Danlos syndrome (EDS) is a group of connective tissue disorders of altered collagen synthesis. People with vascular EDS are at increased risk for vascular and hollow viscous rupture. Heavy menstrual bleeding (HMB) is common among adolescents with EDS. The levonorgestrel intrauterine device (LNG-IUD) is an effective treatment option for HMB; however, its use in patients with vascular EDS has historically been avoided due to perceived risk of uterine rupture. This is the first known case report on use of the LNG-IUD in an adolescent with vascular EDS.CaseA 16-year-old female with vascular EDS and HMB underwent placement of the LNG-IUD. Placement of the device was performed in the operating room under ultrasound guidance. At the 6-month follow-up, the patient reported significant improvement in bleeding and high satisfaction. No complications were identified at the time of placement or follow-up.Summary and conclusionLNG-IUD may be a safe and effective option for menstrual management in individuals with vascular EDS.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

Gynecologic symptoms and the influence on reproductive life in 386 women with hypermobility type ehlers-danlos syndrome: a cohort study 2016

References (11)

Gynecologic symptoms and the influence on reproductive life in 386 women with hypermobility type ehlers-danlos syndrome: a cohort study via openalex
doi:10.1038/ejhg.2015.32 via openalex
W6781739992 via openalex
doi:10.1007/978-3-030-48446-0 via openalex
doi:10.1097/01.ogx.0000251027.32142.63 via openalex
doi:10.2165/11598960-000000000-00000 via openalex
doi:10.1016/j.jpag.2019.12.011 via openalex
doi:10.1016/j.jpag.2021.11.002 via openalex
doi:10.1034/j.1600-0412.2002.810403.x via openalex
doi:10.3109/01443615.2010.484107 via openalex
doi:10.1097/aog.0000000000000123 via openalex

SciLite annotations

chemicals 2

levonorgestrel levonorgestrel

Source provenance

openalex: last seen: 2026-05-11T06:24:00.257642+00:00
scilite: last seen: 2026-05-18T04:26:01.642840+00:00
unpaywall: last seen: 2026-08-16T06:22:10.609676+00:00

License: CC0 · commercial use OK

[1] Gynecologic symptoms and the influence on reproductive life in 386 women with hypermobility type ehlers-danlos syndrome: a cohort study 2016